An expanded biomarker panel for the detection of prostate cancer from urine DNA

ConclusionsThis study shows that large marker panels can be analyzed from urine DNA without loss of sensitivity or specificity. Using 32 markers improved the stratification of patients undergoing screening for PCA particularly for patients below the 10of32 threshold. The results show the utility of larger biomarker panels for PCA diagnosis and suggest that the development of the panels needed to monitor disease progression could be successfully accomplished.
Source: Experimental Hematology and Oncology - Category: Cancer & Oncology Source Type: research